data_1cs9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cs9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.698 0 CA-C-O 119.764 -0.464 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.09 -94.77 1.7 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 122.545 1.081 . . . . 0.0 114.121 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.03 21.34 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 CA-C-N 111.988 -2.106 . . . . 0.0 108.33 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -152.35 -177.28 6.11 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 124.9 1.28 . . . . 0.0 109.496 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 178.566 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.83 -99.23 1.87 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-O 122.737 1.187 . . . . 0.0 115.59 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 pt -121.76 10.35 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 111.905 -2.148 . . . . 0.0 109.317 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.2 tpt85 -154.01 -97.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.608 1.095 . . . . 0.0 110.273 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 CA-C-N 119.764 1.165 . . . . 0.0 112.352 -178.797 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.78 -98.28 0.85 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 119.57 2.588 . . . . 0.0 119.57 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -116.34 30.5 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.972 0 CA-C-N 112.783 -1.709 . . . . 0.0 108.389 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -154.96 141.63 18.94 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.545 0.738 . . . . 0.0 109.244 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.234 0 O-C-N 121.0 -1.063 . . . . 0.0 113.601 177.772 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.57 -148.11 51.12 Favored Glycine 0 N--CA 1.485 1.939 0 CA-C-O 122.918 1.288 . . . . 0.0 112.951 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.0 32.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 CA-C-N 112.732 -1.734 . . . . 0.0 107.028 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -158.3 85.41 0.86 Allowed 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.076 0 O-C-N 121.351 -0.843 . . . . 0.0 114.286 179.114 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.21 -153.62 48.21 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 117.906 0.853 . . . . 0.0 113.938 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.0 tt -54.44 -19.71 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.65 -81.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.205 0.912 . . . . 0.0 109.479 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.362 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 117.695 1.838 . . . . 0.0 117.695 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.56 -156.69 21.66 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 117.819 0.81 . . . . 0.0 114.449 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.49 -10.98 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -157.61 97.65 1.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.843 1.201 . . . . 0.0 109.062 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 CA-C-N 118.948 0.795 . . . . 0.0 113.495 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.21 -154.61 29.04 Favored Glycine 0 N--CA 1.486 1.989 0 CA-C-N 118.373 1.087 . . . . 0.0 114.87 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 pt -54.75 -21.5 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -166.37 136.17 3.21 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.922 0.783 . . . . 0.0 110.497 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 CA-C-N 119.767 1.167 . . . . 0.0 114.469 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.18 -85.56 1.13 Allowed Glycine 0 CA--C 1.541 1.698 0 CA-C-O 119.764 -0.464 . . . . 0.0 114.13 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.09 -94.77 1.7 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 122.545 1.081 . . . . 0.0 114.121 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.03 21.34 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 CA-C-N 111.988 -2.106 . . . . 0.0 108.33 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -152.35 -177.28 6.11 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 124.9 1.28 . . . . 0.0 109.496 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.62 83.83 0.36 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.97 145.37 18.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.054 0.541 . . . . 0.0 111.563 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.247 0.619 . . . . 0.0 109.845 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 C-N-CA 124.354 1.061 . . . . 0.0 113.39 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.5 t . . . . . 0 CA--C 1.554 1.119 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.52 81.46 0.08 OUTLIER Glycine 0 N--CA 1.481 1.668 0 CA-C-N 119.418 1.008 . . . . 0.0 112.643 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.83 -99.23 1.87 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-O 122.737 1.187 . . . . 0.0 115.59 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 pt -121.76 10.35 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 111.905 -2.148 . . . . 0.0 109.317 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.2 tpt85 -154.01 -97.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.608 1.095 . . . . 0.0 110.273 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.12 90.83 0.08 OUTLIER Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.764 1.165 . . . . 0.0 112.352 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -158.59 116.89 2.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -157.15 90.01 1.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.195 -179.54 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.7 78.12 0.09 OUTLIER Glycine 0 N--CA 1.48 1.592 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.78 -98.28 0.85 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 119.57 2.588 . . . . 0.0 119.57 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -116.34 30.5 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.972 0 CA-C-N 112.783 -1.709 . . . . 0.0 108.389 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -154.96 141.63 18.94 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.545 0.738 . . . . 0.0 109.244 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.91 59.2 4.27 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 121.0 -1.063 . . . . 0.0 113.601 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -158.65 -96.9 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -160.87 65.11 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.605 1.548 . . . . 0.0 111.632 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.022 -1.049 . . . . 0.0 109.225 179.354 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.549 0.938 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.63 -106.26 1.48 Allowed Glycine 0 N--CA 1.483 1.832 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.32 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.57 -148.11 51.12 Favored Glycine 0 N--CA 1.485 1.939 0 CA-C-O 122.918 1.288 . . . . 0.0 112.951 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.0 32.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 CA-C-N 112.732 -1.734 . . . . 0.0 107.028 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -158.3 85.41 0.86 Allowed 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 60.18 1.38 Allowed Glycine 0 N--CA 1.487 2.076 0 O-C-N 121.351 -0.843 . . . . 0.0 114.286 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -163.13 119.21 1.79 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -156.61 89.73 1.12 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.461 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.67 -88.55 0.08 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.21 -153.62 48.21 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 117.906 0.853 . . . . 0.0 113.938 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.0 tt -54.44 -19.71 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.65 -81.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.205 0.912 . . . . 0.0 109.479 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.62 81.85 0.17 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -157.47 -84.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -157.62 -66.04 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 119.962 1.256 . . . . 0.0 110.53 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 CA-C-N 120.653 1.569 . . . . 0.0 108.659 -179.545 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 CA--C 1.551 0.992 0 CA-C-O 120.71 0.291 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.6 53.09 46.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 117.695 1.838 . . . . 0.0 117.695 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.56 -156.69 21.66 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 117.819 0.81 . . . . 0.0 114.449 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.49 -10.98 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -157.61 97.65 1.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.843 1.201 . . . . 0.0 109.062 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.44 98.13 1.99 Allowed Glycine 0 N--CA 1.483 1.806 0 CA-C-N 118.948 0.795 . . . . 0.0 113.495 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.53 83.01 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -165.39 128.56 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.588 0.755 . . . . 0.0 109.311 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.74 0 C-N-CA 124.377 1.071 . . . . 0.0 113.375 179.909 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.45 -87.68 0.79 Allowed Glycine 0 N--CA 1.484 1.894 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.223 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.21 -154.61 29.04 Favored Glycine 0 N--CA 1.486 1.989 0 CA-C-N 118.373 1.087 . . . . 0.0 114.87 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 pt -54.75 -21.5 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -166.37 136.17 3.21 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.922 0.783 . . . . 0.0 110.497 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.06 62.89 3.83 Favored Glycine 0 CA--C 1.548 2.102 0 CA-C-N 119.767 1.167 . . . . 0.0 114.469 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -160.49 111.28 1.84 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -151.36 85.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 118.355 -0.831 . . . . 0.0 108.945 -179.514 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.698 0 CA-C-O 119.764 -0.464 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.09 -94.77 1.7 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 122.545 1.081 . . . . 0.0 114.121 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.03 21.34 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 CA-C-N 111.988 -2.106 . . . . 0.0 108.33 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -152.35 -177.28 6.11 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 124.9 1.28 . . . . 0.0 109.496 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 178.566 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.83 -99.23 1.87 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-O 122.737 1.187 . . . . 0.0 115.59 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 pt -121.76 10.35 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 111.905 -2.148 . . . . 0.0 109.317 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.2 tpt85 -154.01 -97.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.608 1.095 . . . . 0.0 110.273 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 CA-C-N 119.764 1.165 . . . . 0.0 112.352 -178.797 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.78 -98.28 0.85 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 119.57 2.588 . . . . 0.0 119.57 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -116.34 30.5 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.972 0 CA-C-N 112.783 -1.709 . . . . 0.0 108.389 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -154.96 141.63 18.94 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.545 0.738 . . . . 0.0 109.244 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.234 0 O-C-N 121.0 -1.063 . . . . 0.0 113.601 177.772 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.57 -148.11 51.12 Favored Glycine 0 N--CA 1.485 1.939 0 CA-C-O 122.918 1.288 . . . . 0.0 112.951 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.0 32.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 CA-C-N 112.732 -1.734 . . . . 0.0 107.028 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -158.3 85.41 0.86 Allowed 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.076 0 O-C-N 121.351 -0.843 . . . . 0.0 114.286 179.114 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.21 -153.62 48.21 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 117.906 0.853 . . . . 0.0 113.938 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.0 tt -54.44 -19.71 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.65 -81.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.205 0.912 . . . . 0.0 109.479 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.362 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 117.695 1.838 . . . . 0.0 117.695 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.56 -156.69 21.66 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 117.819 0.81 . . . . 0.0 114.449 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.49 -10.98 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -157.61 97.65 1.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.843 1.201 . . . . 0.0 109.062 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 CA-C-N 118.948 0.795 . . . . 0.0 113.495 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.21 -154.61 29.04 Favored Glycine 0 N--CA 1.486 1.989 0 CA-C-N 118.373 1.087 . . . . 0.0 114.87 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 pt -54.75 -21.5 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -166.37 136.17 3.21 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.922 0.783 . . . . 0.0 110.497 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 CA-C-N 119.767 1.167 . . . . 0.0 114.469 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.18 -85.56 1.13 Allowed Glycine 0 CA--C 1.541 1.698 0 CA-C-O 119.764 -0.464 . . . . 0.0 114.13 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.09 -94.77 1.7 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 122.545 1.081 . . . . 0.0 114.121 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.03 21.34 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 CA-C-N 111.988 -2.106 . . . . 0.0 108.33 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -152.35 -177.28 6.11 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 124.9 1.28 . . . . 0.0 109.496 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.62 83.83 0.36 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.97 145.37 18.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.054 0.541 . . . . 0.0 111.563 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.247 0.619 . . . . 0.0 109.845 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 C-N-CA 124.354 1.061 . . . . 0.0 113.39 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.5 t . . . . . 0 CA--C 1.554 1.119 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.52 81.46 0.08 OUTLIER Glycine 0 N--CA 1.481 1.668 0 CA-C-N 119.418 1.008 . . . . 0.0 112.643 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.83 -99.23 1.87 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-O 122.737 1.187 . . . . 0.0 115.59 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 pt -121.76 10.35 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 111.905 -2.148 . . . . 0.0 109.317 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.2 tpt85 -154.01 -97.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.608 1.095 . . . . 0.0 110.273 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.12 90.83 0.08 OUTLIER Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.764 1.165 . . . . 0.0 112.352 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -158.59 116.89 2.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -157.15 90.01 1.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.195 -179.54 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.7 78.12 0.09 OUTLIER Glycine 0 N--CA 1.48 1.592 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.78 -98.28 0.85 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 119.57 2.588 . . . . 0.0 119.57 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -116.34 30.5 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.972 0 CA-C-N 112.783 -1.709 . . . . 0.0 108.389 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -154.96 141.63 18.94 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.545 0.738 . . . . 0.0 109.244 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.91 59.2 4.27 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 121.0 -1.063 . . . . 0.0 113.601 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -158.65 -96.9 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -160.87 65.11 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.605 1.548 . . . . 0.0 111.632 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.022 -1.049 . . . . 0.0 109.225 179.354 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.549 0.938 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.63 -106.26 1.48 Allowed Glycine 0 N--CA 1.483 1.832 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.32 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.57 -148.11 51.12 Favored Glycine 0 N--CA 1.485 1.939 0 CA-C-O 122.918 1.288 . . . . 0.0 112.951 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.0 32.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 CA-C-N 112.732 -1.734 . . . . 0.0 107.028 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -158.3 85.41 0.86 Allowed 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 60.18 1.38 Allowed Glycine 0 N--CA 1.487 2.076 0 O-C-N 121.351 -0.843 . . . . 0.0 114.286 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -163.13 119.21 1.79 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -156.61 89.73 1.12 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.461 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.67 -88.55 0.08 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.21 -153.62 48.21 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 117.906 0.853 . . . . 0.0 113.938 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.0 tt -54.44 -19.71 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.65 -81.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.205 0.912 . . . . 0.0 109.479 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.62 81.85 0.17 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -157.47 -84.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -157.62 -66.04 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 119.962 1.256 . . . . 0.0 110.53 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 CA-C-N 120.653 1.569 . . . . 0.0 108.659 -179.545 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 CA--C 1.551 0.992 0 CA-C-O 120.71 0.291 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.6 53.09 46.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 117.695 1.838 . . . . 0.0 117.695 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.56 -156.69 21.66 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 117.819 0.81 . . . . 0.0 114.449 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.49 -10.98 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -157.61 97.65 1.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.843 1.201 . . . . 0.0 109.062 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.44 98.13 1.99 Allowed Glycine 0 N--CA 1.483 1.806 0 CA-C-N 118.948 0.795 . . . . 0.0 113.495 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.53 83.01 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -165.39 128.56 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.588 0.755 . . . . 0.0 109.311 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.74 0 C-N-CA 124.377 1.071 . . . . 0.0 113.375 179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.45 -87.68 0.79 Allowed Glycine 0 N--CA 1.484 1.894 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.223 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.21 -154.61 29.04 Favored Glycine 0 N--CA 1.486 1.989 0 CA-C-N 118.373 1.087 . . . . 0.0 114.87 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 pt -54.75 -21.5 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -166.37 136.17 3.21 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.922 0.783 . . . . 0.0 110.497 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.06 62.89 3.83 Favored Glycine 0 CA--C 1.548 2.102 0 CA-C-N 119.767 1.167 . . . . 0.0 114.469 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -160.49 111.28 1.84 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -151.36 85.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 118.355 -0.831 . . . . 0.0 108.945 -179.514 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.698 0 CA-C-O 119.764 -0.464 . . . . 0.0 114.13 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.09 -94.77 1.7 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 122.545 1.081 . . . . 0.0 114.121 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.03 21.34 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 CA-C-N 111.988 -2.106 . . . . 0.0 108.33 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -152.35 -177.28 6.11 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 124.9 1.28 . . . . 0.0 109.496 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.892 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 178.566 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.668 0 CA-C-O 120.233 -0.204 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.83 -99.23 1.87 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-O 122.737 1.187 . . . . 0.0 115.59 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 pt -121.76 10.35 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 111.905 -2.148 . . . . 0.0 109.317 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.2 tpt85 -154.01 -97.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.608 1.095 . . . . 0.0 110.273 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 CA-C-N 119.764 1.165 . . . . 0.0 112.352 -178.797 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.78 -98.28 0.85 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 119.57 2.588 . . . . 0.0 119.57 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -116.34 30.5 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.972 0 CA-C-N 112.783 -1.709 . . . . 0.0 108.389 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -154.96 141.63 18.94 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.545 0.738 . . . . 0.0 109.244 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 2.234 0 O-C-N 121.0 -1.063 . . . . 0.0 113.601 177.772 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.57 -148.11 51.12 Favored Glycine 0 N--CA 1.485 1.939 0 CA-C-O 122.918 1.288 . . . . 0.0 112.951 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.0 32.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 CA-C-N 112.732 -1.734 . . . . 0.0 107.028 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -158.3 85.41 0.86 Allowed 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.076 0 O-C-N 121.351 -0.843 . . . . 0.0 114.286 179.114 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.623 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.21 -153.62 48.21 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 117.906 0.853 . . . . 0.0 113.938 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.0 tt -54.44 -19.71 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.65 -81.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.205 0.912 . . . . 0.0 109.479 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.362 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 117.695 1.838 . . . . 0.0 117.695 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.56 -156.69 21.66 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 117.819 0.81 . . . . 0.0 114.449 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.49 -10.98 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -157.61 97.65 1.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.843 1.201 . . . . 0.0 109.062 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 CA-C-N 118.948 0.795 . . . . 0.0 113.495 179.896 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.894 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.21 -154.61 29.04 Favored Glycine 0 N--CA 1.486 1.989 0 CA-C-N 118.373 1.087 . . . . 0.0 114.87 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 pt -54.75 -21.5 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -166.37 136.17 3.21 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.922 0.783 . . . . 0.0 110.497 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 2.102 0 CA-C-N 119.767 1.167 . . . . 0.0 114.469 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 28.3 p . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.18 -85.56 1.13 Allowed Glycine 0 CA--C 1.541 1.698 0 CA-C-O 119.764 -0.464 . . . . 0.0 114.13 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.09 -94.77 1.7 Allowed Glycine 0 N--CA 1.487 2.1 0 CA-C-O 122.545 1.081 . . . . 0.0 114.121 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.8 tp -116.03 21.34 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.38 0 CA-C-N 111.988 -2.106 . . . . 0.0 108.33 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -152.35 -177.28 6.11 Favored 'General case' 0 CA--C 1.578 2.028 0 C-N-CA 124.9 1.28 . . . . 0.0 109.496 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.62 83.83 0.36 Allowed Glycine 0 N--CA 1.484 1.892 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.97 145.37 18.26 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.054 0.541 . . . . 0.0 111.563 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.5 ptp180 -158.22 131.94 7.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.247 0.619 . . . . 0.0 109.845 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 C-N-CA 124.354 1.061 . . . . 0.0 113.39 -179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 49.5 t . . . . . 0 CA--C 1.554 1.119 0 CA-C-O 118.703 -0.665 . . . . 0.0 111.729 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.52 81.46 0.08 OUTLIER Glycine 0 N--CA 1.481 1.668 0 CA-C-N 119.418 1.008 . . . . 0.0 112.643 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.83 -99.23 1.87 Allowed Glycine 0 N--CA 1.483 1.825 0 CA-C-O 122.737 1.187 . . . . 0.0 115.59 179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.0 pt -121.76 10.35 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.978 0 CA-C-N 111.905 -2.148 . . . . 0.0 109.317 175.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 52.2 tpt85 -154.01 -97.81 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 119.608 1.095 . . . . 0.0 110.273 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.12 90.83 0.08 OUTLIER Glycine 0 N--CA 1.481 1.645 0 CA-C-N 119.764 1.165 . . . . 0.0 112.352 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -158.59 116.89 2.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -157.15 90.01 1.1 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 118.344 -0.836 . . . . 0.0 109.195 -179.54 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.4 m . . . . . 0 CA--C 1.55 0.963 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.7 78.12 0.09 OUTLIER Glycine 0 N--CA 1.48 1.592 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.78 -98.28 0.85 Allowed Glycine 0 N--CA 1.485 1.914 0 N-CA-C 119.57 2.588 . . . . 0.0 119.57 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.0 pt -116.34 30.5 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.972 0 CA-C-N 112.783 -1.709 . . . . 0.0 108.389 176.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -154.96 141.63 18.94 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.545 0.738 . . . . 0.0 109.244 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.91 59.2 4.27 Favored Glycine 0 CA--C 1.55 2.234 0 O-C-N 121.0 -1.063 . . . . 0.0 113.601 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -158.65 -96.9 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -160.87 65.11 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 120.605 1.548 . . . . 0.0 111.632 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.022 -1.049 . . . . 0.0 109.225 179.354 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 42.0 t . . . . . 0 CA--C 1.549 0.938 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.63 -106.26 1.48 Allowed Glycine 0 N--CA 1.483 1.832 0 CA-C-O 119.312 -0.716 . . . . 0.0 111.32 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.57 -148.11 51.12 Favored Glycine 0 N--CA 1.485 1.939 0 CA-C-O 122.918 1.288 . . . . 0.0 112.951 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.0 32.87 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.578 0 CA-C-N 112.732 -1.734 . . . . 0.0 107.028 174.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -158.3 85.41 0.86 Allowed 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.09 60.18 1.38 Allowed Glycine 0 N--CA 1.487 2.076 0 O-C-N 121.351 -0.843 . . . . 0.0 114.286 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -163.13 119.21 1.79 Allowed 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -156.61 89.73 1.12 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.461 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.67 -88.55 0.08 OUTLIER Glycine 0 N--CA 1.48 1.623 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.21 -153.62 48.21 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 117.906 0.853 . . . . 0.0 113.938 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.0 tt -54.44 -19.71 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.134 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 21.8 tpp85 -157.65 -81.59 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 119.205 0.912 . . . . 0.0 109.479 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.62 81.85 0.17 Allowed Glycine 0 N--CA 1.481 1.684 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -157.47 -84.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -157.62 -66.04 0.09 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-N 119.962 1.256 . . . . 0.0 110.53 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 CA-C-N 120.653 1.569 . . . . 0.0 108.659 -179.545 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.4 p . . . . . 0 CA--C 1.551 0.992 0 CA-C-O 120.71 0.291 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.6 53.09 46.53 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 117.695 1.838 . . . . 0.0 117.695 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.56 -156.69 21.66 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 117.819 0.81 . . . . 0.0 114.449 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.9 pp -57.49 -10.98 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.576 1.976 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -157.61 97.65 1.61 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 119.843 1.201 . . . . 0.0 109.062 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.44 98.13 1.99 Allowed Glycine 0 N--CA 1.483 1.806 0 CA-C-N 118.948 0.795 . . . . 0.0 113.495 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -155.53 83.01 1.04 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -165.39 128.56 2.21 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.588 0.755 . . . . 0.0 109.311 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.74 0 C-N-CA 124.377 1.071 . . . . 0.0 113.375 179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.45 -87.68 0.79 Allowed Glycine 0 N--CA 1.484 1.894 0 CA-C-O 119.617 -0.546 . . . . 0.0 113.223 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 59.21 -154.61 29.04 Favored Glycine 0 N--CA 1.486 1.989 0 CA-C-N 118.373 1.087 . . . . 0.0 114.87 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 25.3 pt -54.75 -21.5 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -166.37 136.17 3.21 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 118.922 0.783 . . . . 0.0 110.497 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.06 62.89 3.83 Favored Glycine 0 CA--C 1.548 2.102 0 CA-C-N 119.767 1.167 . . . . 0.0 114.469 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -160.49 111.28 1.84 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 82.8 mtt85 -151.36 85.82 1.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.234 0 CA-C-O 118.355 -0.831 . . . . 0.0 108.945 -179.514 . . . . . . . . 0 0 . 1 stop_ save_